Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Clover Health Investments Q2 EPS $(0.02) Beats $(0.03) Estimate, Sales $477.620M Beat $468.296M Estimate

Author: Benzinga Newsdesk | August 05, 2025 03:11pm
Clover Health Investments (NASDAQ:CLOV) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.03) by 28.57 percent. This is a 300 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $477.620 million which beat the analyst consensus estimate of $468.296 million by 1.99 percent. This is a 34.07 percent increase over sales of $356.260 million the same period last year.

Posted In: CLOV


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist